SubHero Banner
Text

Pemgarda (pemivibart) – Emergency use authorization approval

March 22, 2024 - The FDA announced the emergency use authorization (EUA) approval of Invivyd’s Pemgarda (pemivibart), for the preexposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and adolescents (12 years of age and older weighing at least 40 kg):

Download PDF